Tag Archives: DES

TAVR: What it says about FDA and CMS

The story has been out for a while about transcatheter aortic valve replacement (TAVR), so maybe it’s time to project into the future. Before we head there, however, we should revisit the past. The pivotal event in this story is…


Medtronic plans to enter ED market

Medtronic has the potential to be a trend setter with its attempt to have drug eluting stents (DES) treat erectile dysfunction (ED). The device maker recently moved one step closer in this effort as it reported that it had completed…


J&J exits DES market

A few weeks ago, I made the mistake of going into the gym around 6 p.m. That’s the time when all the body builders and athletes tend to circulate in the area. I also made the mistake of getting on…